Evaluation of PatientToc in Community Pharmacies
An Evaluation of the Spread and Scale of PatientToc™ From Primary Care to Community Pharmacy Practice for the Collection of Patient-Reported Outcomes: Phase 2
An Evaluation of the Spread and Scale of PatientToc™ From Primary Care to Community Pharmacy Practice for the Collection of Patient-Reported Outcomes: Phase 2
Sponsor study identifier
observational
1,175
1 country
1
Study Start
July 1, 2023
Actual (reported)Primary Completion
March 28, 2024
Actual (reported)Study Completion
March 28, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The purpose of this study is to evaluate the initial "spread and scale" of PatientToc™, a patient-reported outcomes (PROs) collection software, to community pharmacies for the collection and use of PROs data pertaining to medication adherence. The investigators are doing this by engaging PatientToc™ and pharmacy partners in two plan-do-study-act (PDSA) cycles to implement and refine PatientToc™ and an implementation toolkit (i.e., supports/resource tools) within a small number of community pharmacies. Investigators will then scale implementation to more community pharmacies in a rigorous theory-driven evaluation of PatientToc™ implementation using interviews, self-reported data from the pharmacy, observations, and administrative data. Collectively, the findings will inform long-term collection and use of PROs data pertaining to medication use.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 28, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 11, 2022
Actual (reported)February 11, 2022
Actual (reported)July 1, 2023
Actual (reported)March 28, 2024
Actual (reported)March 28, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Self-reported medication adherence, measured by Brief Medication Questionnaire
Validated survey consisting of 4 items asking respondents to consider their medication adherence for each regularly scheduled prescription medication of interest over the past 7 days
Monthly, up to 7 months
Self-reported medication adherence measured by the Merck Medication Adherence Estimator (Adherence Estimator),
Monthly, up to 7 months
Medication regimen complexity measured by the Medication Regimen Complexity Index (MRCI),
Monthly, up to 7 months in select patients only
Pharmacy-level population medication adherence measured by from pharmacy-level EQuIPP data
Prior to and at the end of the intervention
Acceptability of intervention
Monthly, up to 7 months
Adoption of intervention
Monthly, up to 7 months
Pharmacy staff working at pharmacies which have chosen to implement PatientToc software for this implementation science project and evaluation. Pharmacy staff will be observed and participate in interviews pertaining to their experiences using PatientToc.
Patients engaged in completing medication adherence-related questionnaires in the PatientToc software at their pharmacies. Patient-level medication, health history, and self-reported adherence information will be collected from patients meeting eligibility criteria. Patients will also be observed and interviewed about their experiences using PatientToc.
PatientToc has been adapted for use in pharmacies. Patients using specific medications will be prompted to complete questionnaires about their self-reported adherence.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Pharmacy staff and patients at pharmacies agreeing to implement PatientToc as part of this implementation science project.
Purdue University
West Lafayette, Indiana, 46202, United States
Margie E Snyder, PharmD, MPH
Purdue University
First Submitted
January 11, 2022
First Posted
February 11, 2022
Study Start
July 1, 2023
Actual (reported)Primary Completion
March 28, 2024
Actual (reported)Reducing African-American CVD Disparities Intervention Optimization (RADIO) Individuals on Statins
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Study Completion
March 28, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
April 5, 2024
Record last verified: 2024-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: